第四届欧洲生物转化研讨会会议报告
M Walles1, A Pähler2, E M Isin3
1Pharmacokinetic Sciences, Biomedical Research, Novartis, Basel, Switzerland.
Xenobiotica; the fate of foreign compounds in biological systems
|January 5, 2024
概括
第四届欧洲生物转化研讨会强调了先进的生物转化战略和技术. 讨论的重点是新的反应,软件应用,以及尖端的代谢物分析技术,如加速器质谱学.
科学领域:
- 生物化学和制药科学 生物化学和制药科学
- 药物代谢和药理动力学
背景情况:
- 第四届欧洲生物转化研讨会召集专家讨论生物转化当前的挑战和创新.
- 该研讨会是与国际异生菌学会 (ISSX) 和药物代谢和药物相互作用小组 (DMDG) 联合会议合作举办的.
相关概念视频
Bioremediation
18.4K
Bioremediation is the use of prokaryotes, fungi, or plants to remove pollutants from the environment. This process has been used to remove harmful toxins in groundwater as a byproduct of agricultural run-off and also to clean up oil spills.
18.4K
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
212
Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
212


